Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/12/24 16:50 | 3/8/24 | CLVR | Health | Drug | Pharmaceutical Preparations | Hague Henry R III | FL | O | CFO | 3 | S | -3 | 1.18 | 0 | -2 | 376 | D | |||||||||||||||
1/23/24 16:04 | 1/19/24 | CLVR | Health | Drug | Pharmaceutical Preparations | Wilches Julian | FL | O | Chief Re | 4 | S | -1 | 0.9086 | 0 | -1 | 0 | 921 | D | ||||||||||||||
1/23/24 16:03 | 1/19/24 | CLVR | Health | Drug | Pharmaceutical Preparations | Fajardo Andres | FL | DO | CEO | 4 | S | -6 | 1.21 | 0 | -5 | 0 | 1,112 | D | ||||||||||||||
6/30/23 16:03 | 6/29/23 | CLVR | Health | Drug | Pharmaceutical Preparations | Muecke William | FL | D | 1 | S | 0 | 0.2072 | 0 | 0 | 0 | 166 | D | |||||||||||||||
6/30/23 16:01 | 6/29/23 | CLVR | Health | Drug | Pharmaceutical Preparations | Julien Gary M | FL | D | 1 | S | 0 | 0.2072 | 0 | 0 | 0 | 122 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |